24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension
Hae-Young Lee, Cheol-Ho Kim, Jae-Kwan Song, Shung Chull Chae, Myung Ho Jeong, Dong-Soo Kim, Byung-Hee Oh
Korean J Intern Med. 2017;32(6):1025-1036.   Published online 2017 Oct 17     DOI: https://doi.org/10.3904/kjim.2016.094
Citations to this article as recorded by Crossref logo
Fimasartan: A new armament to fight hypertension
Akshyaya Pradhan, Vikas Gupta, Rishi Sethi
Journal of Family Medicine and Primary Care.2019; 8(7): 2184.     CrossRef
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives
Fabio Angeli, Paolo Verdecchia, Monica Trapasso, Marina Pane, Sara Signorotti, Gianpaolo Reboldi
Expert Opinion on Drug Metabolism & Toxicology.2018; 14(5): 533.     CrossRef